HER2 insertion YVMA mutant lung cancer: long natural history and response to afatinib

Human epidermal growth factor 2 (HER2, ERBB2) mutations in lung cancers are oncogenic drivers that respond to HER2 targeted therapies. Little is known about the sensitivity of subtypes of HER2 mutant lung cancers to targeted agents. We present a patient with HER2 mutant lung cancer with a 12 base pa...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Lung Cancer
Hoofdauteurs: Li, Bob T., Lee, Adrian, O'Toole, Sandra, Cooper, Wendy, Yu, Bing, Chaft, Jamie E., Arcila, Maria E., Kris, Mark G., Pavlakis, Nick
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2015
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4724317/
https://ncbi.nlm.nih.gov/pubmed/26559459
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.lungcan.2015.10.025
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items